RCMI Coordinating Center (RCMI CC) Header Logo

Connection

George Perry to Recombinant Proteins

This is a "connection" page, showing publications George Perry has written about Recombinant Proteins.
Connection Strength

0.120
  1. Aliev G, Shenk JC, Fischbach K, Perry G. Stem cell niches as clinical targets: the future of anti-ischemic therapy? Nat Clin Pract Cardiovasc Med. 2008 Sep; 5(9):590-1.
    View in: PubMed
    Score: 0.071
  2. Talmadge JE, Jackson JD, Kelsey L, Borgeson CD, Faltynek C, Perry GA. T-cell reconstitution by molecular, phenotypic, and functional analysis in the thymus, bone marrow, spleen, and blood following split-dose polychemotherapy and therapeutic activity for metastatic breast cancer in mice. J Immunother Emphasis Tumor Immunol. 1993 Nov; 14(4):258-68.
    View in: PubMed
    Score: 0.026
  3. Wang X, Yan MH, Fujioka H, Liu J, Wilson-Delfosse A, Chen SG, Perry G, Casadesus G, Zhu X. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum Mol Genet. 2012 May 01; 21(9):1931-44.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support